Go Deep
CellSource Co., Ltd.
CellSource Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,678 | 62.2 | 1.01 | 0.01 | 187.06 |
CellSource Co., Ltd. Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 781,879,000.0 | 915,572,000.0 | 860,016,000.0 | 893,361,000.0 |
| Net Profit | 103,294,000.0 | 37,572,000.0 | 33,618,000.0 | -75,617,000.0 |
| EPS | — | — | 1.7 | — |
CellSource Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
| Revenue | 3,711,455,000.0 | 4,355,063,000.0 | 4,510,544,000.0 | 4,273,829,000.0 | — |
| Net Profit | 10,659,000.0 | 237,940,000.0 | 923,142,000.0 | 1,017,842,000.0 | — |
| EPS | 0.5 | 12.0 | 48.9 | 54.5 | — |
CellSource Co., Ltd. Balance Sheet
| Line Item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
| Total Assets | 7,023,969,000.0 | 7,074,909,000.0 | 6,879,736,000.0 | 4,599,680,000.0 | — |
| Total Liabilities | 1,007,145,000.0 | 1,037,809,000.0 | 677,739,000.0 | 814,151,000.0 | — |
| Total Equity | 6,016,824,000.0 | 6,037,100,000.0 | 6,201,997,000.0 | 3,785,529,000.0 | — |
Owes vs Owns
CellSource Co., Ltd. owed ¥0.13 for every ¥1 it owned in Jul 2026, down from ¥0.18 in Oct 2022.
| Period | Jul 2026 | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.13× | 0.14× | 0.15× | 0.10× | 0.18× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
CellSource Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Oct 2025
Cash & short-term investments 67.1%Receivables 4.8%Inventory 3.8%Fixed assets (tangible) 18.2%Intangible assets 0.8%Long-term investments 1.6%Other assets 3.8%
How it's funded — Oct 2025
Long-term debt 0.5%Payables 0.9%Other liabilities 12.7%Shareholders' equity 85.7%
| Line Item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4,711.8 | 4,320.9 | 4,781.0 | 3,123.6 |
| Receivables | 338.0 | 328.8 | 364.3 | 657.3 |
| Inventory | 266.2 | 283.8 | 305.9 | 227.0 |
| Fixed assets (tangible) | 1,277.0 | 1,473.6 | 1,046.5 | 260.5 |
| Intangible assets | 56.4 | 58.4 | 19.8 | 10.5 |
| Long-term investments | 110.7 | 131.5 | 0.0 | 171.4 |
| Other assets | 263.8 | 477.8 | 362.2 | 149.3 |
| Liabilities & equity | ||||
| Short-term debt | 20.9 | 20.6 | 20.3 | 0.0 |
| Long-term debt | 35.8 | 56.7 | 77.3 | 0.0 |
| Payables | 61.9 | 93.1 | 75.5 | 109.7 |
| Other liabilities | 888.5 | 867.5 | 504.7 | 704.5 |
| Shareholders' equity | 6,016.8 | 6,037.1 | 6,202.0 | 3,785.5 |
| Net tangible assets | 5,960.4 | 5,978.7 | 6,182.2 | 3,775.0 |
CellSource Co., Ltd. Cash Flow
| Line Item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
| Operating Activities | 333,095,000.0 | 591,723,000.0 | 846,691,000.0 | 847,603,000.0 | — |
| Investing Activities | -3,292,000.0 | -614,961,000.0 | -624,080,000.0 | -169,388,000.0 | — |
| Financing Activities | 61,071,000.0 | -437,244,000.0 | 1,449,123,000.0 | 14,421,000.0 | — |